This announcement is a separate document:
北京市兰台律师事务所关于黑龙江珍宝岛药业股份有限公司2023年限制性股票激励计划部分限制性股票回购注销实施的法律意见书
Legal opinion of Lantai Law Firm of Beijing on the implementation of the cancellation of restricted stock repurchase of Heilongjiang ZBD Pharmaceutical Co., Ltd.'s 2023 restricted stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated